Literature DB >> 4369835

Cellular immunity to herpes simplex virus mediated by interferon.

D L Lodmell, A L Notkins.   

Abstract

Rabbit kidney cell monolayers infected with herpes simplex virus (HSV) were incubated with leukocytes from rabbits immunized with complete Freund's adjuvant. When the leukocytes were exposed to tuberculin purified protein derivative (PPD), viral replication and plaque formation were markedly inhibited. Similarly, when leukocytes from animals immunized with HSV were exposed to UV-inactivated HSV, viral replication was markedly inhibited. Exposure of leukocytes from unimmunized animals or animals immunized with incomplete Freund's adjuvant to UV-inactivated virus or PPD produced relatively little inhibition of viral replication. Examination of supernatant fluids from stimulated cultures revealed a soluble mediator that had the properties of interferon. Interferon production was detected within several hours after exposure of sensitized leukocytes to antigen. Supernatant fluids from as few as one sensitized leukocyte per 200 rabbit kidney cells inhibited HSV replication by over 90%. These findings support the concept that the cellular immune response to HSV consists of two phases: an immunologically specific antigen recognition phase, and a nonspecific effector phase that stops HSV spread by generating interferon.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4369835      PMCID: PMC2139616          DOI: 10.1084/jem.140.3.764

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Improved assays for a variety of interferons. 1.

Authors:  H K Oie; C E Buckler; C P Uhlendorf; D A Hill; S Baron
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

2.  Release of virus inhibitor from tuberculin-sensitized peritoneal cells stimulated by antigen.

Authors:  L M Milstone; B H Waksman
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

Review 3.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

Authors:  B Hampar; A L Notkins; M Mage; M A Keehn
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

5.  Inhibition or enhancement of immunological injury of virus-infected cells.

Authors:  A M Brier; C Wohlenberg; J Rosenthal; M Mage; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

6.  Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals.

Authors:  L A Glasgow
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

7.  Selective increase in lymphocyte interferon response to vaccinia antigen after revaccination.

Authors:  L B Epstein; D A Stevens; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

8.  Cell-mediated immunity in Herpesvirus hominis infections.

Authors:  J M Wilton; L Ivanyi; T Lehner
Journal:  Br Med J       Date:  1972-03-18

9.  Immune specific induction of interferon production in cultures of human blood lymphocytes.

Authors:  J A Green; S R Cooperband; S Kibrick
Journal:  Science       Date:  1969-06-20       Impact factor: 47.728

10.  In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.

Authors:  G L Rosenberg; P A Farber; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

View more
  20 in total

1.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

2.  Mechanism of induction of cell-mediated immunity to virus infections: in vitro inhibition of intracellular multiplication of mouse adenovirus by immune spleen cells.

Authors:  C Hamada; H Uetake
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

3.  Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection.

Authors:  J J Hooks; W Burns; K Hayashi; S Geis; A L Notkins
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

5.  Reactivation of latent herpes simplex virus infection of the autonomic nervous system by postganglionic neurectomy.

Authors:  R W Price; J Schmitz
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

6.  Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.

Authors:  M B Dunlop
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

7.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.

Authors:  A Knoblich; J Görtz; V Härle-Grupp; D Falke
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Inhibition of herpes simplex virus multiplication by activated macrophages: a role for arginase?

Authors:  P Wildy; P G Gell; J Rhodes; A Newton
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.

Authors:  L Caspary; B Schindling; S Dundarov; D Falke
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes.

Authors:  Y M Centifanto; Z S Zam; H E Kaufman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.